Ontology highlight
ABSTRACT:
SUBMITTER: Nakashima Y
PROVIDER: S-EPMC6131115 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
Nakashima Yuko Y Setou Mitsutoshi M
Mass spectrometry (Tokyo, Japan) 20180911 1
Oligonucleotide-based therapeutics such as antisense oligonucleotides, small interfering RNAs (siRNAs), decoy and aptamer have been extensively developed. To investigate the pharmacokinetics of oligonucleotide therapeutics, it is common to label a radioisotope in a nucleic acid and visualize it. However, if the labeled terminal nucleotide is decomposed by a nuclease <i>in vivo</i>, only the labeled nucleotide is detected, and it is impossible to observe the nucleic acid exhibiting the drug effec ...[more]